Publications
-
Mohammad F, Weissmann S, Leblanc B, Pandey DP, Højfeldt JW, Comet I, Zheng C, Johansen JV, Rapin N, Porse BT, Tvardovskiy A, Jensen ON, Gene-Olaciregui N, Lavarino C, Suñol M, de Torres C, Mora J, Carcaboso AM and Helin K.
EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas
NATURE MEDICINE . 23(4): 483-492. Number of citations: 390
-
Monterrubio C, Paco-Mercader S, Gene-Olaciregui N, Pascual-Pastó G, Vilà-Ubach M, Cuadrado-Vilanova M, Ferrandiz MM, Castillo-Ecija H, Glisoni R, Kuplennik N, Jungbluth A, de Torres C, Lavarino C, Cheung NV, Mora J, Sosnik A and Carcaboso AM.
Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8
JOURNAL OF CONTROLLED RELEASE . 255: 108-119. Number of citations: 35
-
Hennika T, Hu G, Gene-Olaciregui N, Barton KL, Ehteda A, Chitranjan A, Chang C, Gifford AJ, Tsoli M, Ziegler DS, Carcaboso AM and Becher OJ.
Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models
PLoS One . 12(1): . Number of citations: 130
-
Fang X, Zhou W, Wu Q, Huang Z, Shi Y, Yang K, Chen C, Xie Q, Mack SC, Wang X, Carcaboso AM, Sloan AE, Ouyang G, McLendon RE, Bian XW, Rich JN and Bao S.
Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination
JOURNAL OF EXPERIMENTAL MEDICINE . 214(1): 245-267. Number of citations: 121
-
Pascual-Pastó G, Gene-Olaciregui N, Vilà-Ubach M, Paco-Mercader S, Monterrubio C, Rodriguez E, Winter U, Batalla-Vilacís M, Català-Mora J, Salvador-Hernandez H, Parareda A, Schaiquevich P, Suñol M, Mora J, Lavarino C, de Torres C, Chantada G and Carcaboso AM.
Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination
CANCER LETTERS . 380(1): 10-19. Number of citations: 25
-
Jansen MH, Lagerweij T, Sewing AC, Vugts DJ, van Vuurden DG, Molthoff CF, Caretti V, Veringa SJ, Petersen N, Carcaboso AM, Noske DP, Vandertop WP, Wesseling P, van Dongen GA, Kaspers GJ and Hulleman E.
Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models
MOLECULAR CANCER THERAPEUTICS . 15(9): 2166-2174. Number of citations: 50
-
Winter U, Mena HA, Negrotto S, Arana E, Pascual-Pastó G, Laurent V, Suñol M, Chantada G, Carcaboso AM and Schaiquevich P.
Schedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma Cells
PLoS One . 11(7): . Number of citations: 21
-
Hernandez-Muñoz I, Figuerola-Bou E, Sánchez-Molina S, Rodriguez E, Fernández-Mariño AI, Pardo-Pastor C, Bahamonde MI, Fernández-Fernández JM, García-Domínguez DJ, Hontecillas-Prieto L, Lavarino C, Carcaboso AM, de Torres C, Tirado OM, de Alava E and Mora J.
RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-?B pathway, independently of the fusion oncoprotein
Oncotarget . 7(29): 46283-46300. Number of citations: 12
-
Rodriguez-Hernandez CJ, Mateo-Lozano S, Garcia-López M, Casalà C, Briansó F, Castrejon N, Rodriguez E, Suñol M, Carcaboso AM, Lavarino C, Mora J and de Torres C.
Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens
Oncotarget . 7(13): 16112-16129. Number of citations: 17
-
Monterrubio C, Pascual-Pastó G, Cano F, Vilà-Ubach M, Manzanares-Quintela A, Schaiquevich P, Tornero JA, Sosnik A, Mora J and Carcaboso AM.
SN-38-loaded nanofiber matrices for local control of pediatric solid tumors after subtotal resection surgery
Biomaterials . 79: 69-78. Number of citations: 42